| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |